6533b85ffe1ef96bd12c1c5b

RESEARCH PRODUCT

Risk Factors for Pulmonary Embolism in Patients with Paralysis and Deep Venous Thrombosis

Thomas MünzelKarsten KellerKarsten KellerIngo SagoschenVolker SchmittJens WöllnerMir Abolfazl OstadLukas HobohmChristine Espinola-klein

subject

medicine.medical_specialtyCOPDpulmonary embolismbusiness.industryRGeneral Medicineparalysismedicine.diseaseThrombophlebitisstrokemortalityArticlespinal cord injuryPulmonary embolismVenous thrombosisInternal medicineHeart failureParalysismedicineMedicinecardiovascular diseasesmedicine.symptombusinessStrokeCause of death

description

Background. Venous thromboembolism is a frequent complication and an important cause of death in patients with paralysis. We aimed to investigate predictors of pulmonary embolism (PE) and the impact of PE on the survival of patients with paralysis in comparison to those with deep venous thrombosis or thrombophlebitis (DVT). Methods: Patients were selected by screening the German nationwide inpatient sample (2005–2017) for paralysis, and were stratified for venous thromboembolism (VTE) and the VTE-sub-entity PE (ICD-code I26). Impact of PE on mortality and predictors for PE were analyzed. Results: Overall, 7,873,769 hospitalizations of patients with paralysis were recorded in Germany 2005–2017, of whom 1.6% had VTE and 7.0% died. While annual hospitalizations increased (2005: 520,357 to 2017: 663,998) (β 12,421 (95% CI 10,807 to 14,034), p &lt

yearjournalcountryeditionlanguage
2021-11-01Journal of Clinical Medicine
10.3390/jcm10225412http://dx.doi.org/10.3390/jcm10225412